EMERYVILLE, Calif., July 16, 2018 (GLOBE NEWSWIRE) -- In support of its growth strategy to become a global leader in Clean Beauty, Amyris (NASDAQ: AMRS ) has announced two executive appointments to ensure it can respond quickly to the surging consumer demand for its Clean Beauty skincare products from Biossance™, now the fastest selling skincare brand in North America.
Caroline Hadfield has been promoted to President of Biossance, and is recognized for leading its launch and subsequent success with consumers looking for clean, non-toxic skincare that delivers superior performance. Formerly Senior Vice President of Personal Care at Amyris, Ms. Hadfield will continue to lead brand positioning, new product and category innovation and development, supply chain management and operations. A leading advocate for the introduction of Clean Beauty in the skincare market, she has successfully established Biossance as a leader in this rapidly growing sector of the market, delivering an outstanding range of Clean Beauty products that meet our No Compromise™ philosophy of safe, non-toxic ingredients that are efficacious and deliver superior performance.
In addition, Catherine Gore will join as Senior Vice President, Sales, Marketing & Education for Biossance. Formerly, a Global Vice President and General Manager of Kendo, including Marc Jacobs Beauty, and the Vice President of Merchandising for Sephora Collection, Ms. Gore will be responsible for revenue growth and sales channel execution both domestically and internationally. Ms. Gore brings a strong track record of delivering significant revenue growth from her recent experience.
“With these two appointments, Biossance is well positioned to accelerate its growth in Clean Beauty categories, as well as expand its reach, both internationally and online,” Amyris President and CEO John Melo said. “This year, Biossance retail sales have climbed 300%. We have successfully set the standard for Clean Beauty in the skincare market and we are growing rapidly in response to consumer demand.”
“We are delivering positive impact for our planet and our shareholders by setting the standard for sustainability in personal care. Using products with sustainable ingredients is not just a good choice, we believe it’s the best choice,” Mr. Melo said. “We make higher quality, sustainable products that perform better. That is what we mean by Make Good. No Compromise.™ In the near future, we expect to disrupt Baby Care, the way we are doing with skincare. We believe that everybody’s skin, no matter how young or old, deserves the benefits of clean, non-toxic ingredients, without any petroleum or harmful chemicals.”
About Biossance Pioneering sustainable beauty through biotechnology, at Biossance we created a 100% plant-based squalane skincare line that is delivering the leading skin moisturizer while using only safe and sustainable ingredients. We formulate with a No Compromise™ approach, proudly blacklisting over 2,000 potentially harmful ingredients because the products you use make a difference for your health and the health of the planet. Biossance makes sure only the most trustworthy and powerful ingredients make the final cut. Because we believe and are committed to delivering both best performing and clean beauty products. The full Biossance skin care line can be found at www.Biossance.com and www.SEPHORA.com .
About Amyris Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise™ products and services across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. More information about the company is available at www.amyris.com .
Forward-Looking Statements This release contains forward-looking statements, and any statements other than statements of historical fact could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events (such as expected growth for Biossance, including anticipated international and online expansion, and the expected introduction of Baby Care products), that involve risks and uncertainties. These statements are based on management's current expectations and actual results and future events may differ materially due to risks and uncertainties, including risks related to Amyris's liquidity and ability to fund operating and capital expenses, potential delays or failures in development, production and commercialization of products, risks related to Amyris's reliance on third parties, and other risks detailed from time to time in filings Amyris makes with the Securities and Exchange Commission, including Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Amyris disclaims any obligation to update information contained in these forward-looking statements, whether as a result of new information, future events, or otherwise.
Amyris, the Amyris logo, Biossance and No Compromise are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries. All other trademarks are the property of their respective owners.
Contact: Peter DeNardo Director, Investor Relations and Corporate Communications Amyris, Inc. +1 (510) 740-7481 investor@amyris.com pr@amyris.com
